主要研究方向为卫生政策评估与卫生经济学。近五年发表BMJ、Lancet Oncol、JAMA Pediatr、 BMJ Glob Health、 Value Health、 Soc Sci Med 等高水平英文期刊论文（SSCI & SCI）60余篇，中文核心期刊论文30余篇。主持国家社会科学基金重大项目1项，国家自然科学基金3项，天津市生物医药重大专项1项、天津市自然科学基金2项。主编和副主编《药物经济学》教材4部，主编《中国药物经济学评价指南2025》，牵头发布《临床试验加载药物经济学评价专家共识2024》、《卫生技术评估中疗效与安全性间接比较证据生成专家共识（2026）》。

• 卫生经济学与药物经济学
  卫生与药品政策评估
  真实世界医疗大数据分析
  健康相关生命质量与健康效用测量

• 天津市创新人才推进计划中青年科技创新领军人才
• 天津市教育系统优秀共产党员
• 天津市优秀教师
• 天津大学“十佳杰出青年”
• 中国商业联合会全国服务业科技创新一等奖

• Ambiguous guideline recommendations harm patient care.BMJ.2026
• The social distribution of quality adjusted life expectancy (QALE) among social deprivation subgroups in China.Value Health.2026
• Measuring health spillover effects in household members of adolescents and elderly individuals with health issues in China.Qual Life Res.2026
• Does DRG-based payment lead to unintended effects on care quality? A case under global budget with price adjustment in China.BMC Health Serv R....2025
• Can DRG payment under global budget with price adjustment curb te soaring healthcare costs? Insights from China's reform and its underlying mechanism.BMC Public Health....2025
• Evaluation of measurement properties of the Health Assessment Questionnaire-Disability Index (HAQ-DI) among gout patients in China.Health Qual Life ....2025
• How Does Disease Severity Affect Clinical Outcomes and Economic Burden of Patients with COPD -- A Retrospective Population-Based Cohort Study in Tianjin, China.Int J Chron Obstr....2025
• Development of the County-Level Social Deprivation Index 2020 and Its Association With Health Outcomes in China.Value Health.2025
• Assessing the economic burden and health-related quality of life in chinese patients with fibrodysplasia ossificans progressiva: a questionnaire survey analysis.Orphanet J Rare D....2025
• Impact of pooled procurement of medicines on patient adherence and economic burden: evidence from China.J Glob Health.2025
• Disutility of Treatment-related Attributes for Type 2 Diabetes Mellitus: A Systematic Review.Quality of Life R....2025
• Are There Differences in Health State Preferences between Urban and Rural Respondents? A Comparison using Time Trade-off and Discrete Choice Experiment.European Journal ....2025
• Deriving Health Utility Values using Mapping Methods among Chinese Population: A Systematic Review.Applied Health Ec....2025
• Testing the unintended cost effects of health policies for generic substitutions: the case of China's National Volume-Based Procurement (NVBP) policy.Health Policy Pla....2025
• Entecavir for children and adults with chronic hepatitis B.Cochrane Database....2025
• Do machine learning approaches perform better than regression models in mapping studies? A systematic review.Value Health.2025
• The generic version of China Health Related Outcomes Measures (CHROME-G): Psychometric testing and comparative performance with the EQ-5D-5L and SF-6Dv2 among the Chinese general population.BMC Public Health.2024
• Is the Use of Unanchored Matching-Adjusted Indirect Comparison Always uperior to Naïve Indirect Comparison on Survival Outcomes? A Simulation Study.Applied Health Ec....2025
• Efficiency must not compromise trustworthiness in rating certainty and formulating recommendations in AI era.BMJ.2025
• Efficacy, Safety, and Treatment Burden of Aflibercept 2 mg and Ranibizumab in Retinal Vein Occlusion: A Systematic Review and Meta-Analysis.Ophthalmol Ther.2024
• Enhancing the Interpretation of Continuous Outcomes and Subgroup Analyses in Systematic Reviews.JAMA Pediatr.2024
• Impact of China’s national volume-based procurement on drug procurement price, volume, and expenditure: an interrupted time series analysis in Tianjin.International Jou....2023
• Incorporating absolute effects to enrich interpretation of findings from meta-analyses.The Lancet Oncolo....2023
• Diversity when interpreting evidence in network meta-analyses (NMAs) on similar topics: an example case of NMAs on diabetic macular oedema.Systematic Review....2023
• Can case-based payment contain healthcare costs? - A curious case from China.Soc Sci Med.2022
• Cost Effectiveness of the First-in-Class ARNI (Sacubitril/Valsartan) for the Treatment of Essential Hypertension in a Chinese Setting.Pharmacoeconomics.2022
• Policy Updates on Access to and Affordability of Innovative Medicines in China.Value Health Reg ....2022
• Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life.Eur J Health Econ.2022
• China Health Related Outcomes Measures (CHROME): Development of a New Generic Preference-Based Measure for the Chinese Population.Pharmacoeconomics.2022
• How Do Treatment Preferences of Patients With Cancer Compare With Those of Oncologists and Family Members? Evidence From a Discrete Choice Experiment in China.Value Health.2022
• Incorporating future unrelated medical costs in cost-effectiveness analysis in China.BMJ Global Health.2021
• Eliciting SF-6Dv2 Health State Utilities Using An Anchored Best-Worst Scaling Technique.Social Science & ....2021
• Valuation of SF-6Dv2 Health States in China Using Time Trade-off and Discrete-Choice Experiment with a Duration Dimension.Pharmacoeconomics.2021
• Do discrete choice experiments approaches perform better than time trade-off in eliciting health state utilities? Evidence from SF-6Dv2 in China.Value in Health.2022
• The impact of China’s National Essential Medicine Policy and its implications for urban outpatients: a multivariate difference-in-differences study.Value in Health.2017
• 临床试验加载药物经济学评价专家共识（2024版）.中华医学杂志.2024
• 集中带量采购非中选药品医保支付标准确定规则的实证探索.中国卫生经济.2025
• 中国2型糖尿病患者对口服降糖药支付意愿研究：基于离散选择实验..中华糖尿病杂志
• 基于真实世界数据的重度哮喘患者药物治疗现状实证研究.中国医院药学杂志
• 药物经济学评价贴现率测量方法研究综述.中国卫生经济
• 结节性痒疹患者真实世界数据的流行病学和疾病负担特征分析.中国皮肤性病学杂志
• 基于患者个体数据的疗效间接比较方法学综述与应用选择.中国循证医学杂志
• 药物经济学在促进临床合理用药中的应用与展望.中国医院药学杂志
• 引入公平性信息的卫生经济性评价方法与研究进展.药物流行病学杂志
• 我国基本医疗保险报销政策对成人血友病A患者治疗水平与费用的影响.中华医院管理杂志
• 全民医保下的药品价格形成与支付标准思考.中国社会保障
• 中国2型糖尿病患者慢性并发症患病率与次均医疗费用研究.中华内分泌代谢杂志.2019
• 真实世界证据在英国药品管理准入协议中的应用——以CAR-T药品为例.中国食品药品监管.2024
• 新质生产力视角下医疗大数据驱动的医药经济学研究.中国卫生经济
• 真实世界数据用于药品经济价值评价的关键技术研究.中国循证医学杂志.2024
• 美国DRG下高值创新医疗技术的支付政策及启示.中国医疗保险.2022
• 天津市慢性冠脉综合征患者抗血栓药物治疗现状真实世界研究.中国医院药学杂志
• 天津市基本医疗保险丙肝按人头付费政策评估.中国医疗保险.2019
• 无锚定匹配调整间接比较方法简介及实例应用.中国循证医学杂志.2023
• 我国门诊慢性病保障制度实施现状分析.中国医疗保险.2023
• EQ-HWB量表健康状态分级系统构建述评与经验启示.中国卫生政策研究.2022
• 绝经后女性骨质疏松患者骨折发生情况及相关医疗费用研究.中国慢性病预防与控制.2021
• 天津市新诊断2型糖尿病患者慢性并发症发病率与相关医疗费用研究.中国卫生统计.2021
• DRG分组策略与支付标准界定的国内外比较.中国医疗保险.2021
• 中国药品价格水平变化实证研究.中国药学杂志.2020
• 国内外普适性健康效用量表综述研究.中国卫生政策研究.2020